pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
ONO-2808
Multiple System Atrophy (Multi-System Degeneration)
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 1
ONO-2910
Diabetic Neuropathy
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 1
OP-3136
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$OLMAOlema Pharmaceuticals, Inc.
0 catalysts
Preclinical
← prev
page 136 of 271
next →
131
Pain89
Neurology1
OPB-171775
Gastrointestinal Stromal Tumor (GIST)
$BDRXBiodexa Pharmaceuticals Plc
0 catalysts
Phase 2
OPC-1
Acute Spinal Cord Injury
5-hydroxytryptamine receptor 2AD(2) dopamine receptor
$LCTXLineage Cell Therapeutics, Inc.
0 catalysts
Phase 1
OPC-214870
Epilepsy
Otsuka Pharmaceutical Co Ltd
0 catalysts
Phase 2
OPCT-001
Retinal Degeneration
BlueRock Therapeutics LP
0 catalysts
OPDIVO
OPDIVO (NIVOLUMAB)
1 INDICATIONS AND USAGE OPDIVO QVANTIG is a combination of nivolumab, a progr…
Programmed cell death protein 1
$BMYBRISTOL MYERS SQUIBB CO
0 catalysts
OPDIVO QVANTIG
OPDIVO QVANTIG (NIVOLUMAB)
1 INDICATIONS AND USAGE OPDIVO QVANTIG is a combination of nivolumab, a progr…
Programmed cell death protein 1
$BMYBRISTOL MYERS SQUIBB CO
0 catalysts
Phase 2
OPF-310
Type 1 Diabetes (Juvenile Diabetes)
Otsuka Pharmaceutical Co Ltd
0 catalysts
Phase 2
OPGx-BEST1
Macular Degeneration
$IRDOpus Genetics, Inc.
0 catalysts
Preclinical
OPGx-CNGB1
Retinitis Pigmentosa (Retinitis)
$IRDOpus Genetics, Inc.
0 catalysts
Phase 3
OPGx-LCA5
Leber Congenital Amaurosis (LCA)
$IRDOpus Genetics, Inc.
0 catalysts
Preclinical
OPGx-RDH12
Leber Congenital Amaurosis (LCA)
$IRDOpus Genetics, Inc.
0 catalysts
Preclinical
OPGx-RHO
Retinitis Pigmentosa (Retinitis)
$IRDOpus Genetics, Inc.
0 catalysts
Preclinical
OPK-88006
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$OPKOPKO HEALTH, INC.
0 catalysts
Phase 1
OPL-009
Hypertension
Overseas Pharmaceuticals Ltd
0 catalysts
Phase 3
OPL-015
Pain
Overseas Pharmaceuticals Ltd
0 catalysts
Phase 1
OPN-6602
Refractory Multiple Myeloma
Opna Bio SA
0 catalysts
Preclinical
OPTF-01
Glioblastoma Multiforme (GBM)
Optieum Biotechnologies Inc
0 catalysts
OPTIONELLE
OPTIONELLE (LEVONORGESTREL TABLET, 1.5 MG)
NAARI PTE
0 catalysts
OPTIRAY 320
OPTIRAY 320 (IOVERSOL)
LIEBEL-FLARSHEIM
0 catalysts
OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES
OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES (HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN)
GE HEALTHCARE
0 catalysts
Preclinical
OQL-036
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome)
OnQuality Pharmaceuticals LLC
0 catalysts
Preclinical
OQY-8811
Multiple Myeloma (Kahler Disease)
Oqory Inc
0 catalysts
Preclinical
OR-449
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Orphagen Pharmaceuticals Inc
0 catalysts
Preclinical
OR-812
Male Contraception
Orphagen Pharmaceuticals Inc
0 catalysts
Preclinical
ORG-101
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Orgenesis Inc
0 catalysts
ORGOVYX
ORGOVYX (RELUGOLIX)
Sumitomo Pharma America Inc
0 catalysts
ORILISSA
ORILISSA (ELAGOLIX SODIUM)
1 INDICATIONS AND USAGE ORILISSA is indicated for the management of moderate…
Gonadotropin-releasing hormone receptor
$ABBVAbbVie Inc.
0 catalysts